BAY-184 is a selective oral inhibitor of KAT6A and KAT6B with IC50 values of 71 nM and 83 nM, respectively. This compound suppresses estrogen receptor alpha (ERalpha) transcriptional activity and impedes cell proliferation across various breast cancer subtypes as well as tumor growth.
Molekulargewicht:
420.48
Reinheit:
98.87%
CAS Nummer:
[2520347-03-7]
Formel:
C23H20N2O4S
Target-Kategorie:
Estrogen Receptor/ERR|||Histone Acetyltransferase
T203636
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten